Insiders AxoGen, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 21/06/2024 am IST			5-day change	1st Jan Change
6.81 ^USD	-4.76%		-13.03%	-0.29%

28/05	Axogen, Inc. Announces the Opening of its Axogen Processing Center	CI
16/05	AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft	MT

Axogen Insider Sold Shares Worth $319,891, According to a Recent SEC Filing	09/03	MT
AxoGen, Inc. Announces Executive Changes	09/03	CI
Axogen Expects Higher Q4 Revenue; CEO Plans to Retire	05/01	MT
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025	05/01	CI
Axogen, Inc. Announces Plans to Retirement of Karen Zaderej as President, Effective January 2025	05/01	CI
AxoGen, Inc. Announces Executive Changes	05/01	CI
Axogen, Inc. Appoints Kathy Weiler to its Board of Directors	27/12	CI
AxoGen, Inc. Announces Executive Changes	06/23/06	CI
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer	13/23/13	CI
Insider Sell: Axogen	28/23/28	MT
Insider Sell: Axogen	19/22/19	MT
Insider Sell: Axogen	17/22/17	MT
Axogen, Inc. Announces Directorate Changes	31/22/31	CI
Eric Sandberg, Current Chief Commercial Officer Will Be Leaving AxoGen, Inc	19/22/19	CI
Axogen, Inc. Appoints William Burke to Board of Directors	11/22/11	CI
AxoGen, Inc. Announces Board Changes	02/22/02	CI
Axogen, Inc. Appoints John H. Johnson to Board of Directors and to Both the Governance, Nominating and Sustainability Committee and the Science and Technology Committee	20/21/20	CI
Insider Trends: Insider Disposition Eases Back 90-Day Buy Trend at AxoGen	04/21/04	MT
Axogen, Inc. Promotes Peter J. Mariani to Executive Vice President	02/21/02	CI
Insider Trends: Insider Sales Add to 90-Day Trend at AxoGen	13/21/13	MT

No results for this search